Juvisync Available for Type 2 Diabetes and High Cholesterol - MPR

Links shared publicly online about this topic.

  • 0
    total visits

Juvisync Available for Type 2 Diabetes and High Cholesterol - MPR

empr.com

Merck announced that Juvisync, a fixed-dose combination product containing the dipeptidyl peptidase 4 (DPP-4) inhibitor sitagliptin and the HMG-CoA reductase inhibitor simvastatin is now available.

View full resource at empr.com

Tags: Cholesterol, Cholesterol Medication, Diabetes, Diabetes Type 2 Medication, Type 2 Diabetes, Zocor, Januvia, Merck & Co.

  • Share

Most Recently Shared on October 26, 2011 at 1:57 pm By:

Two-Drug Tablet for Diabetics with High Cholesterol Approved - Renal and Urology News

renalandurologynews.com — “The FDA has approved Juvisync, a combination prescription medication for patients with both type 2 diabetes and high cholesterol.View full resource at renalandurologynews.com

  • View Related
  • Share

Most Recently Shared on October 12, 2011 at 4:11 pm By:

RxEconsult, LLC - Juvisync (sitagliptin & simvastatin) for treating type 2 diabetes and elevated cholesterol

rxeconsult.com — “RxEconsult, LLC - Juvisync (sitagliptin & simvastatin) for treating type 2 diabetes and elevated cholesterolView full resource at rxeconsult.com

  • View Related
  • Share

Most Recently Shared on October 11, 2011 at 12:25 am By:

RxEconsultRxEconsult. If you are in need of healthcare services or information, please visit RxEconsult. 

Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.

Dr. Ogbru has written several journal articles. In 1997, he shared an award from the American Journal of Pain Management for Outstanding Contribution to the Interdisciplinary Pain Management Literature. Over the last 12 years Dr. Ogbru has held several roles in the pharmaceutical industry, including Director of Global Medical Information and Communication." /> Ome Ogbru, PharmD Active Health Library, Doctor, Pharmacist, and PharmD

Recently approved #Juvisync: First combination pill for treating #diabetes and high #cholesterol http://t.co/WxtT8NLx #medication #health

6 months ago...

FDA OKs diabetes, cholesterol combo drug - Related Stories - DiabetesPro SmartBrief

smartbrief.com — “Merck & Co. secured marketing approval from the FDA for Juvisync, a treatment containing the firm's type 2 diabetes pill Januvia and cholesterol-lowering statin simvastatin. The combination was approved for marketing in multiple strengths. "Dose selection should factor in what other drugs the patie…View full resource at smartbrief.com

  • View Related
  • Share

Most Recently Shared on October 10, 2011 at 4:03 pm By:

nutritionjill Jill Weisenberger Nutritionist and Dietitian

Available in 6 dosages RT @Eatingsoulfully: FDA OKs diabetes, cholesterol combo drug http://t.co/5Wp37M2a #diabetes

6 months ago...

Juvisync Approved for Type 2 Diabetics With High Cholesterol --Doctors Lounge

doctorslounge.com — “Juvisync Approved for Type 2 Diabetics With High Cholesterol --Doctors LoungeView full resource at doctorslounge.com

  • View Related
  • Share

Most Recently Shared on October 8, 2011 at 12:37 am By:

Drugs_Devices Drugs and Devices OW OW Health

Juvisync Approved for Type 2 Diabetics With High Cholesterol: Previously approved meds combined in one tablet http://t.co/8hWqpjDA

6 months ago...

FDA Approves Juvisync for Diabetes, High Cholesterol : Internal Medicine News

internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice treView full resource at internalmedicinenews.com

  • View Related
  • Share

Most Recently Shared on October 7, 2011 at 7:46 pm By:

MedicalNewsNet Bob Finn - Medical News Net Health News

FDA approves Juvisync, the first product to combine a drug for type 2 diabetes with a cholesterol-lowering drug - http://t.co/Mfbtsp03

6 months ago...

Sitagliptin And Simvastatin Combination - Juvisync - Approved By FDA For Diabetes With High Cholesterol

medicalnewstoday.com — “The first single tablet for both diabetes type 2 and high cholesterol, Juvisync (sitagliptin and simvastatin), has been approved by the FDA (Food and Drug Administration). Sitagliptin and simvastaView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 7, 2011 at 7:05 pm By:

mnt_cholesterol MNT Cholesterol News Health News

Sitagliptin And Simvastatin Combination - Juvisync - Approved By FDA For Diabetes With High Cholesterol http://mnt.to/429R #cholesterol

6 months ago...

Advertisement